Cystatin C model: Ka (h-1) = 0.45 ·
[1+(-0.449) · (if dosage=capsule preparations)] · [1+(-0.959) ·
(if dosage=enteric-coated tablets)]; CL (L/h) = 9.86 · (cystatin
C/4.21) -0.543 · (myeloperoxidase/36.5)
0.154; Vp (L) = 408.33 ·
(albumin/39.3); |
Cystatin C model: Ka
(h-1) = 0.45 · [1+(-0.449) · (if dosage=capsule
preparations)] · [1+(-0.959) · (if dosage=enteric-coated
tablets)]; CL (L/h) = 9.86 · (cystatin C/4.21)
-0.543 · (myeloperoxidase/36.5)
0.154; Vp (L) = 408.33 ·
(albumin/39.3); |
Cystatin C model: Ka
(h-1) = 0.45 · [1+(-0.449) · (if dosage=capsule
preparations)] · [1+(-0.959) · (if dosage=enteric-coated
tablets)]; CL (L/h) = 9.86 · (cystatin C/4.21)
-0.543 · (myeloperoxidase/36.5)
0.154; Vp (L) = 408.33 ·
(albumin/39.3); |
Cystatin C model: Ka
(h-1) = 0.45 · [1+(-0.449) · (if dosage=capsule
preparations)] · [1+(-0.959) · (if dosage=enteric-coated
tablets)]; CL (L/h) = 9.86 · (cystatin C/4.21)
-0.543 · (myeloperoxidase/36.5)
0.154; Vp (L) = 408.33 ·
(albumin/39.3); |
Cystatin C model: Ka
(h-1) = 0.45 · [1+(-0.449) · (if dosage=capsule
preparations)] · [1+(-0.959) · (if dosage=enteric-coated
tablets)]; CL (L/h) = 9.86 · (cystatin C/4.21)
-0.543 · (myeloperoxidase/36.5)
0.154; Vp (L) = 408.33 ·
(albumin/39.3); |
Cystatin C model: Ka
(h-1) = 0.45 · [1+(-0.449) · (if dosage=capsule
preparations)] · [1+(-0.959) · (if dosage=enteric-coated
tablets)]; CL (L/h) = 9.86 · (cystatin C/4.21)
-0.543 · (myeloperoxidase/36.5)
0.154; Vp (L) = 408.33 ·
(albumin/39.3); |